Welcome to our dedicated page for Scientific Ind news (Ticker: SCND), a resource for investors and traders seeking the latest updates and insights on Scientific Ind stock.
Scientific Industries, Inc. (OTCQB: SCND) is a life science tool provider and manufacturing company whose news flow centers on its DOTS bioprocessing systems, VIVID vision-based pill counters, and Torbal weighing products. Company press releases highlight its role as a developer of digitally simplified bioprocessing products and pharmacy automation solutions used in laboratories and pharmacies.
On this page, readers can follow SCND news related to quarterly and annual financial results, operational updates in its Benchtop Laboratory Equipment Operations and Bioprocessing Systems Operations, and developments in its AI-enabled product roadmap. Recent announcements have covered revenue trends in the Torbal Division, changes in Bioprocessing Systems revenues, and the impact of macroeconomic conditions such as tariffs and research funding on customer purchasing patterns, as described by the company.
Scientific Industries also issues news about strategic transactions and capital raises, including the sale of substantially all assets of its Genie Division to Troemner, LLC and private placements intended to support advancement of the DOTS platform. Investors and observers can find updates on the company’s strategic refocus toward pharmacy automation and biomanufacturing, as well as commentary on how these moves are expected to support its data-driven platforms.
Another recurring theme in SCND news is product and technology progress. Releases describe AI-powered features for the VIVID WORKSTATION, machine learning-enabled pill counting, and enhancements to the DOTS MPS platform, along with references to peer-reviewed validation and customer studies. The news feed also includes notices of investor conference presentations and investor calls tied to Form 10-Q filings. This page aggregates such company-issued updates so readers can review Scientific Industries’ own descriptions of its performance, strategy, and product evolution over time.
Scientific Industries (OTCQB:SCND) reported a net loss of $703,300 for the year ending June 30, 2020, translating to ($0.46) per share, compared to a net income of $645,600 or $0.43 per share in 2019. Revenues declined by 16% to $8,570,300 due to COVID-19 related order reductions, particularly in Q4. Increased operating expenses were attributed to product development and restructuring costs. However, the company is optimistic about recovery, citing improving revenue trends and demand, and successfully closed a $6.1 million equity capital raise.
Scientific Industries (OTCQB:SCND) is set to engage in a virtual presentation at the October 2020 Lytham Partners Virtual Investor Growth Conference on October 7, 2020, at 4:00 p.m. ET. A webcast will be available on the company's investor relations page and can also be accessed via Lytham Partners' website.
Additionally, management will conduct virtual one-on-one meetings, which can be arranged through Lytham Partners.
Scientific Industries specializes in laboratory equipment and bioprocessing systems, serving various research sectors.